Biochemical Evaluation of Copper Compounds Derived from O- and N-/O- Donor Ligands
- 79 Downloads
- 1 Citations
Compounds [CuII 2(benz)4(Hbenz)2] (1) and [CuII(ppa)2(H2O)2] n (2), where benz = benzoate and ppa = 3-pyridinepropionic acid, were synthesized and studied for their 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity and the inhibition of enzymes such as acetylcholinesterase (AChE), butyrylcholinesterase (BChE), lipoxygenase (LOX), urease, chymotrypsin and α-glucosidase. The synthesized compounds were also studied by hemolytic method for their cytotoxicity and found to be low-toxicity substances. For AChE inhibition, compound 2 showed IC50 = 31.22 ± 0.45 μM, as compared to compound 1with IC50 = 36.52 ± 0.44 μM. Both compounds showed comparably low activity against BChE and were also active against urease, but compound 1 exhibited selective anti-urease activity. The anti-α-glucosidase activity of both compounds was comparable with that of standard drug used.
Keywords
copper complexes benzoate 3-pyridinepropionic acid antioxidant activity α-enzyme inhibition hemolytic activityReferences
- 1.(a) R. Sessoli, D. Gatteschi, A. Caneschi, M. A. Novak, Nature, 365, 141 – 143 (1993); (b) P. Horcajada, R. Gref, T. Baati, et al., Chem. Rev., 112, 1232 – 1268 (2012).Google Scholar
- 2.(a) M. D. Allendorf, C. A. Bauer, R. K. Bhakta, and R. J. T. Houka, Chem. Soc. Rev., 38, 1330 – 1352 (2009); (b) S. Mukhopadhyay, S. K. Mandal, S. Bhaduri, and W. H. Armstrong, Chem. Rev., 104, 3981 – 4026 (2004).Google Scholar
- 3.(a) S. Rafique, M. Idrees, A. Nasim, et, al., J. Biotech. Mol. Bio. Rev., 5(2), 38 – 45 (2010); (b) D. Chen, V. Milacic, M. Frezza, and Q. P. Dou, Curr. Pharm. Des., 15(7), 777 – 791 (2009).Google Scholar
- 4.O. M. Yaghi, H. L. Li, C. Davis, et al., Acc. Chem. Res., 31, 474 – 484 (1998).CrossRefGoogle Scholar
- 5.M. J. Zaworotko, Chem. Soc. Rev., 23, 283 – 288 (1994).CrossRefGoogle Scholar
- 6.(a) N. Raman, J. Joseph, A. Sakthivel, and R. Jeyamurugan, J. Chil. Chem. Soc., 54, 354 – 357 (2009); (b) J. R. Sorenson, J. Chem. Br., 1110 – 1113 (1984).Google Scholar
- 7.M. Alkan, H. Yüksek, Ö. G.-Kol, and M. Calapoðlu, Molecules, 13(1), 107 – 121 (2008).Google Scholar
- 8.(a) S. Nochi, N. Asakawa, and T. Sato, Biol. Pharm. Bull., 18, 1145 – 1147 (1995); (b) W. Tong, E. R. Collantes, Y. Chen, and W. J. Welsh, J. Med. Chem., 39, 380 – 387 (1996).Google Scholar
- 9.Q. Yu, H. W. Holloway, T. Utsuki, et al., J. Med. Chem., 42, 1855 – 1861 (1999).CrossRefPubMedGoogle Scholar
- 10.M. Ikram, S.-U. Rehman, S. Rehman, et al. Inorg. Chim. Acta, 390, 210 – 216 (2012).CrossRefGoogle Scholar
- 11.(a) M. Arfan, M. Ali, H. Ahmad, et al., J. Enz. Inhib. Med. Chem., 25, 296 – 299 (2010); (b) L. Zhang, S. B. Mulrooney, A. F. K. Leung, et al., Biometals, 19, 503 – 511 (2006).Google Scholar
- 12.J. F. G. Vliegenthart and G. A. Veldink, Free Radicals in Biology, W. A. Pryor (ed.), Academic Press, New York (1982),Vol. 5, pp. 29 – 64.Google Scholar
- 13.M. J. Nelson, S. Seitz, In Active Oxygen in Biochemistry, J. S. Valentine, C. S. Foote, A. Greenberg, and J. F. Liebman, (eds.), Chapman and Hall, Glasgow (1995), pp. 276 – 312.Google Scholar
- 14.O. Motabar, Z. D. Shi, E. Goldin, et al., Anal. Biochem., 390, 79 – 84 (2009).CrossRefPubMedPubMedCentralGoogle Scholar
- 15.(a) N. Yasumatsu, Y. Yoshikawa, Y. Adachi, and H. Sakurai, Bioorg. Med. Chem., 15, 4917 – 4922 (2007); (b) H. Sakurai, A. Katoh, and Y. Yoshikawa, Bull. Chem. Soc. Jpn., 79, 1645 – 1664 (2006).Google Scholar
- 16.M. N. Akhtar, W. T. A. Harrison, M. Shahid, et al., Transition Met. Chem., 41, 325 – 330 (2016).CrossRefGoogle Scholar
- 17.(a) T. Kawata, H. Uekusaand, and S. Ohba, Acta Cryst. B, 48, 253 – 261 (1992); (b) Y.-H. Wang, M.-C. Suen, H.-T. Lee, and J.-C. Wang, Polyhedron, 25, 2944 – 2952 (2006).Google Scholar
- 18.N. Noor, R. A. Sarfraz, S. Y. Ali, and M. Shahid, Food Chem., 143, 362 – 366 (2014).CrossRefPubMedGoogle Scholar
- 19.G. L. Ellman, K. D. Courtney, V. Andres, and R. M. Featherstone, Biochem. Pharmacol., 7, 88 – 95 (1961).CrossRefPubMedGoogle Scholar
- 20.A. L. Tappel, Arch. Biochem. Biophys., 44(2), 378 – 395 (1953).CrossRefPubMedGoogle Scholar
- 21.M. W. Weatherburn, Anal. Chem., 39, 971 – 974 (1967).CrossRefGoogle Scholar
- 22.A. Lodhi, M. I. Choudhary, M. M. Ahmad, and S. Ahmad, J. Enz. Inhib. Med. Chem., 23(3), 400 – 405 (2008).CrossRefGoogle Scholar
- 23.P. Chapdelaine, R. Roland, Tremblay, and J. Y. Dube, Clin. Chem., 24, 208 – 211 (1978).Google Scholar
- 24.W. Zheng, J. Li, Z. Qiu, et al., Toxicol. Appl. Pharmacol., 264, 65 – 72 (2012).CrossRefPubMedGoogle Scholar
- 25.Q. Yu, H. W. Holloway, T. Utsuki, et al., J. Med. Chem., 42, 1855 – 1861 (1999).CrossRefPubMedGoogle Scholar
- 26.C. Geula and S. Darvesh, Drugs Today, 40, 711 – 721 (2004).CrossRefPubMedGoogle Scholar
- 27.B. Ashley, Neurobiol. Aging, 23(6), 1031 – 1038 (2002).CrossRefGoogle Scholar
- 28.J. Patocka, K. Kuca, D. Jun, Acta Medica, 47(4), 215 – 228 (2004).PubMedGoogle Scholar
- 29.G. F. Makhaeva, A. Y. Aksinenko, V. B. Sokolov, et al., Bioorg. Med. Chem. Lett., 19(19), 5528 – 5530 (2009).CrossRefPubMedGoogle Scholar
- 30.N. H. Greig, T. Utsuki, D. K. Ingram, et al., Proc. Natl. Acad. Sci. USA, 102, 17213 – 172218 (2005).CrossRefPubMedPubMedCentralGoogle Scholar
- 31.N. H. Greig, T. Utsuki, Q. Yu, et al. Curr. Med. Res. Opin., 17, 159 – 165 (2001).CrossRefPubMedGoogle Scholar